Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 10.38 CAD 0.39% Market Closed
Market Cap: 866.4m CAD
Have any thoughts about
Extendicare Inc?
Write Note

Intrinsic Value

The intrinsic value of one EXE stock under the Base Case scenario is 12.95 CAD. Compared to the current market price of 10.38 CAD, Extendicare Inc is Undervalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EXE Intrinsic Value
12.95 CAD
Undervaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Extendicare Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EXE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EXE?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Extendicare Inc

Provide an overview of the primary business activities
of Extendicare Inc.

What unique competitive advantages
does Extendicare Inc hold over its rivals?

What risks and challenges
does Extendicare Inc face in the near future?

Summarize the latest earnings call
of Extendicare Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Extendicare Inc.

Provide P/S
for Extendicare Inc.

Provide P/E
for Extendicare Inc.

Provide P/OCF
for Extendicare Inc.

Provide P/FCFE
for Extendicare Inc.

Provide P/B
for Extendicare Inc.

Provide EV/S
for Extendicare Inc.

Provide EV/GP
for Extendicare Inc.

Provide EV/EBITDA
for Extendicare Inc.

Provide EV/EBIT
for Extendicare Inc.

Provide EV/OCF
for Extendicare Inc.

Provide EV/FCFF
for Extendicare Inc.

Provide EV/IC
for Extendicare Inc.

Show me price targets
for Extendicare Inc made by professional analysts.

What are the Revenue projections
for Extendicare Inc?

How accurate were the past Revenue estimates
for Extendicare Inc?

What are the Net Income projections
for Extendicare Inc?

How accurate were the past Net Income estimates
for Extendicare Inc?

What are the EPS projections
for Extendicare Inc?

How accurate were the past EPS estimates
for Extendicare Inc?

What are the EBIT projections
for Extendicare Inc?

How accurate were the past EBIT estimates
for Extendicare Inc?

Compare the revenue forecasts
for Extendicare Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Extendicare Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Extendicare Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Extendicare Inc compared to its peers.

Compare the P/E ratios
of Extendicare Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Extendicare Inc with its peers.

Analyze the financial leverage
of Extendicare Inc compared to its main competitors.

Show all profitability ratios
for Extendicare Inc.

Provide ROE
for Extendicare Inc.

Provide ROA
for Extendicare Inc.

Provide ROIC
for Extendicare Inc.

Provide ROCE
for Extendicare Inc.

Provide Gross Margin
for Extendicare Inc.

Provide Operating Margin
for Extendicare Inc.

Provide Net Margin
for Extendicare Inc.

Provide FCF Margin
for Extendicare Inc.

Show all solvency ratios
for Extendicare Inc.

Provide D/E Ratio
for Extendicare Inc.

Provide D/A Ratio
for Extendicare Inc.

Provide Interest Coverage Ratio
for Extendicare Inc.

Provide Altman Z-Score Ratio
for Extendicare Inc.

Provide Quick Ratio
for Extendicare Inc.

Provide Current Ratio
for Extendicare Inc.

Provide Cash Ratio
for Extendicare Inc.

What is the historical Revenue growth
over the last 5 years for Extendicare Inc?

What is the historical Net Income growth
over the last 5 years for Extendicare Inc?

What is the current Free Cash Flow
of Extendicare Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Extendicare Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Extendicare Inc

Current Assets 236.8m
Cash & Short-Term Investments 136.4m
Receivables 82.3m
Other Current Assets 18.1m
Non-Current Assets 469.6m
Long-Term Investments 25.9m
PP&E 279.1m
Intangibles 123.8m
Other Non-Current Assets 40.7m
Current Liabilities 396.1m
Accounts Payable 224.2m
Other Current Liabilities 171.9m
Non-Current Liabilities 203.5m
Long-Term Debt 163.7m
Other Non-Current Liabilities 39.9m
Efficiency

Earnings Waterfall
Extendicare Inc

Revenue
1.4B CAD
Cost of Revenue
-1.2B CAD
Gross Profit
175.5m CAD
Operating Expenses
-91.3m CAD
Operating Income
84.3m CAD
Other Expenses
-24.8m CAD
Net Income
59.4m CAD

Free Cash Flow Analysis
Extendicare Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EXE Profitability Score
Profitability Due Diligence

Extendicare Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
ROE is Increasing
ROIC is Increasing
59/100
Profitability
Score

Extendicare Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

EXE Solvency Score
Solvency Due Diligence

Extendicare Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Long-Term Solvency
Average D/E
Low Altman Z-Score
40/100
Solvency
Score

Extendicare Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 10.71 CAD with a low forecast of 9.6 CAD and a high forecast of 12.08 CAD.

Lowest
Price Target
9.6 CAD
8% Downside
Average
Price Target
10.71 CAD
3% Upside
Highest
Price Target
12.08 CAD
16% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EXE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Nov 24, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for EXE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Extendicare Inc Logo
Extendicare Inc

Country

Canada

Industry

Health Care

Market Cap

866.4m CAD

Dividend Yield

5.78%

Description

Extendicare, Inc. is a holding company, which engages in the provision of nursing care, home health care, retirement living, and management and consulting services. The company is headquartered in Markham, Ontario. The firm's segments include long-term care, retirement living, home health care, and contract services, consulting and group purchasing as other operations. The company owns and operates 58 long-term care homes with a capacity for 8,138 residents. Under the Esprit Lifestyle Communities brand, it owns and operates approximately 11 retirement communities with 1,050 suites. Through its wholly owned subsidiary ParaMed, its home health care operations provide complex nursing care, occupational, physical and speech therapy, and assistance with daily activities to accommodate those living at home. Through its Extendicare Assist division, it provides contract services and consulting to third parties. Through its SGP Purchasing Partner Network division, it offers purchasing contracts to other senior care providers for food, capital equipment, furnishings, cleaning and nursing supplies, and office products.

Contact

ONTARIO
Markham
3000 Steeles Ave E Suite 700
+19054705534.0
www.extendicare.com

IPO

1980-03-17

Employees

23 000

Officers

CEO, President & Director
Dr. Michael R. Guerriere M.D., MBA
Senior VP & CFO
Mr. David E. Bacon
Senior Vice President of ParaMed & CTO
Mr. Steve Paraskevopoulos
Senior VP, Chief Legal Officer & Corporate Secretary
Mr. John Toffoletto
Chief Medical Officer
Dr. Matthew Morgan
VP of Information Technology & Chief Information Officer
Joe Belinsky
Show More
Vice President of Investor Relations
Ms. Jillian E. Fountain
Vice President of Public Affairs
Ms. Danielle Labossiere Parr
Vice President of Corporate Development
Ms. Kathryn Killoran Bradley
Senior VP & Chief Human Resources Officer
Ms. Katie LeMoyne
Show Less

See Also

Discover More
What is the Intrinsic Value of one EXE stock?

The intrinsic value of one EXE stock under the Base Case scenario is 12.95 CAD.

Is EXE stock undervalued or overvalued?

Compared to the current market price of 10.38 CAD, Extendicare Inc is Undervalued by 20%.

Back to Top